Connexins and Pannexins in cerebral ischemia

Yeri Kim1, Joanne O Davidson2, Colin R Green1

  • 1Department of Ophthalmology, Faculty of Medical and Health Sciences, University of Auckland.

Insights

Cerebral ischemia, a brain blood flow loss, causes cell death via inflammatory pathways. Connexin and Pannexin channels are key targets for treating this condition.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pathology

Background:

  • Cerebral ischemia, or brain ischemia, is a leading cause of death and adult disability globally.
  • It results from sudden blood flow loss, leading to unmet brain metabolic demands and cell death.
  • Inflammatory pathways are activated, causing irreversible brain tissue damage.

Purpose of the Study:

  • To review the roles of Connexin and Pannexin channels in cerebral ischemia-induced cell death.
  • To highlight these channels as potential therapeutic targets for brain ischemia.
  • To focus on connexin hemichannels' role in ATP release during ischemia and reperfusion.

Main Methods:

  • Literature review of studies on Connexins and Pannexins in cerebral ischemia.
  • Analysis of the time-dependent roles of these channels in ischemic injury.
  • Examination of their involvement in cell death mechanisms and ATP release.

Main Results:

  • Connexin and Pannexin channels play significant, time-dependent roles in perpetuating ischemic injury.
  • Connexin hemichannels are implicated in substantial ATP release during both ischemia and reperfusion.
  • These channels are involved in various cell death pathways following ischemic events.

Conclusions:

  • Connexin and Pannexin channels represent promising therapeutic targets for mitigating cerebral ischemia.
  • Targeting connexin hemichannels may offer a strategy to reduce ischemia-reperfusion injury.
  • Further research into these channels could lead to novel treatments for brain ischemia and its consequences.